Highest Net Margin — Healthcare
Net profit margin shows the percentage of revenue that translates into profit.
439 companies with Net Margin data.
Ranked by Net Margin(439)
| # | Ticker | Name | Market Cap | Net Margin |
|---|---|---|---|---|
| 1 | DBVT | DBV TECHNOLOGIES S.A. | $1.2B | 2744.4% |
| 2 | PAVM | PAVMED INC. | $9M | 1328.6% |
| 3 | EW | EDWARDS LIFESCIENCES CORPORATION | $50.2B | 76.7% |
| 4 | KRYS | KRYSTAL BIOTECH, INC. | $8.1B | 52.6% |
| 5 | ADMA | ADMA BIOLOGICS, INC. | $3.7B | 46.4% |
| 6 | NL | NL INDUSTRIES, INC. | $302M | 46.1% |
| 7 | SIGA | Siga Technologies INC | $463M | 42.7% |
| 8 | UTHR | United Therapeutics Corporation | $21.7B | 41.5% |
| 9 | PTCT | PTC THERAPEUTICS, INC. | $5.5B | 39.4% |
| 10 | UTMD | UTAH MEDICAL PRODUCTS, INC. | $212M | 33.9% |
| 11 | EXEL | EXELIXIS, INC. | $11.4B | 33.7% |
| 12 | KLAC | KLA CORP | $199.8B | 33.4% |
| 13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | $126.2B | 32.9% |
| 14 | LLY | ELI LILLY AND COMPANY | $992.4B | 31.7% |
| 15 | REGN | REGENERON PHARMACEUTICALS, INC. | $82.6B | 31.4% |
| 16 | BIO | BIO-RAD LABORATORIES, INC. | $7.5B | 29.4% |
| 17 | JNJ | Johnson & Johnson | $598.7B | 28.5% |
| 18 | ISRG | Intuitive Surgical, Inc. | $178.8B | 28.4% |
| 19 | RMD | ResMed Inc. | $37.3B | 27.2% |
| 20 | UG | UNITED-GUARDIAN, INC. | $31M | 26.7% |
| 21 | MRK | Merck & Co., Inc. | $306.1B | 26.7% |
| 22 | IRMD | IRADIMED CORPORATION | $1.3B | 26.3% |
| 23 | INCY | INCYTE CORPORATION | $20.2B | 25.0% |
| 24 | IDXX | IDEXX LABORATORIES INC /DE | $52.4B | 24.6% |
| 25 | ACAD | ACADIA PHARMACEUTICALS INC. | $4.2B | 23.6% |
| 26 | SBC | SBC Medical Group Holdings Incorporated | $396M | 22.7% |
| 27 | HALO | HALOZYME THERAPEUTICS, INC. | $8.2B | 22.7% |
| 28 | MTD | Mettler-Toledo International Inc. | $27.8B | 21.6% |
| 29 | WAT | WATERS CORP /DE/ | $31.3B | 21.6% |
| 30 | AMGN | AMGEN INC | $209.2B | 21.0% |
| 31 | CORT | CORCEPT THERAPEUTICS INC | $3.8B | 20.9% |
| 32 | LNTH | LANTHEUS HOLDINGS, INC. | $5.0B | 20.4% |
| 33 | LMAT | LEMAITRE VASCULAR, INC. | $2.5B | 20.0% |
| 34 | CHE | CHEMED CORPORATION | $5.8B | 19.7% |
| 35 | ILMN | Illumina, Inc. | $20.6B | 19.6% |
| 36 | PG | PROCTER & GAMBLE CO | $388.6B | 19.0% |
| 37 | A | Agilent Technologies, Inc. | $34.3B | 18.8% |
| 38 | DXCM | DEXCOM, INC. | $28.3B | 17.9% |
| 39 | MEDP | Medpace Holdings, Inc. | $12.8B | 17.8% |
| 40 | NRC | National Research Corporation | $304M | 17.3% |
| 41 | GYRE | Gyre Therapeutics, Inc. | $794M | 16.9% |
| 42 | NBIX | NEUROCRINE BIOSCIENCES, INC. | $13.3B | 16.7% |
| 43 | WST | WEST PHARMACEUTICAL SERVICES, INC. | $18.3B | 16.1% |
| 44 | INSP | Inspire Medical Systems, Inc. | $1.8B | 15.9% |
| 45 | SRTS | Sensus Healthcare, Inc. | $68M | 15.9% |
| 46 | CDNA | CAREDX, INC. | $965M | 15.7% |
| 47 | BMRN | BioMarin Pharmaceutical Inc | $11.9B | 15.0% |
| 48 | BCPC | Balchem Corporation | $5.9B | 14.9% |
| 49 | MSA | MSA SAFETY INCORPORATED | $7.6B | 14.9% |
| 50 | ABT | Abbott Laboratories | $202.3B | 14.7% |
| 51 | WDFC | WD-40 COMPANY | $3.2B | 14.7% |
| 52 | BMY | BRISTOL-MYERS SQUIBB COMPANY | $127.0B | 14.6% |
| 53 | BSX | BOSTON SCIENTIFIC CORPORATION | $114.0B | 14.4% |
| 54 | CL | COLGATE-PALMOLIVE COMPANY | $79.5B | 14.4% |
| 55 | MDT | Medtronic plc | $125.4B | 13.9% |
| 56 | HOLX | HOLOGIC INC | $16.8B | 13.8% |
| 57 | JAZZ | Jazz Pharmaceuticals plc | $11.7B | 13.8% |
| 58 | PDEX | PRO-DEX, INC. | $142M | 13.5% |
| 59 | ECL | ECOLAB INC. | $86.9B | 13.4% |
| 60 | SRPT | SAREPTA THERAPEUTICS, INC. | $1.8B | 13.2% |
| 61 | BIIB | BIOGEN INC. | $28.2B | 13.1% |
| 62 | MMM | 3M COMPANY | $87.1B | 13.0% |
| 63 | SYK | STRYKER CORP | $148.3B | 12.9% |
| 64 | PFE | PFIZER INC | $157.2B | 12.6% |
| 65 | OPXS | OPTEX SYSTEMS HOLDINGS, INC. | $90M | 12.5% |
| 66 | HAE | HAEMONETICS CORPORATION | $2.9B | 12.3% |
| 67 | MDXG | MIMEDX GROUP, INC. | $724M | 12.2% |
| 68 | CHD | CHURCH & DWIGHT CO., INC. | $24.8B | 11.9% |
| 69 | ELMD | ELECTROMED, INC. | $196M | 11.8% |
| 70 | UFPT | UFP Technologies, Inc. | $1.6B | 11.7% |
| 71 | CLX | THE CLOROX COMPANY | $15.4B | 11.4% |
| 72 | IPAR | INTERPARFUMS, INC. | $3.2B | 11.3% |
| 73 | STE | STERIS plc | $24.7B | 11.3% |
| 74 | THC | TENET HEALTHCARE CORP | $20.8B | 11.1% |
| 75 | CHRS | COHERUS ONCOLOGY, INC. | $250M | 10.7% |
| 76 | ULS | UL Solutions Inc. | $16.9B | 10.6% |
| 77 | ALGN | ALIGN TECHNOLOGY, INC. | $13.6B | 10.5% |
| 78 | DTIL | Precision BioSciences, Inc. | $101M | 10.4% |
| 79 | GEHC | GE HEALTHCARE TECHNOLOGIES INC. | $38.4B | 10.1% |
| 80 | PPG | PPG INDUSTRIES, INC. | $27.6B | 9.9% |
| 81 | RVTY | Revvity, Inc. | $11.0B | 9.8% |
| 82 | RIGL | RIGEL PHARMACEUTICALS, INC. | $631M | 9.8% |
| 83 | MNKD | MannKind Corporation | $1.0B | 9.7% |
| 84 | REX | REX AMERICAN RESOURCES CORPORATION | $1.2B | 9.5% |
| 85 | RPM | RPM International Inc. | $14.6B | 9.3% |
| 86 | COO | COOPER COMPANIES, INC. | $16.4B | 9.2% |
| 87 | PODD | INSULET CORPORATION | $17.4B | 9.1% |
| 88 | HCA | HCA Healthcare, Inc. | $118.5B | 9.0% |
| 89 | CBT | Cabot Corporation | $4.0B | 8.9% |
| 90 | MMSI | MERIT MEDICAL SYSTEMS INC | $4.6B | 8.9% |
| 91 | DGX | Quest Diagnostics Inc | $23.4B | 8.8% |
| 92 | CON | CONCENTRA GROUP HOLDINGS PARENT, INC | $3.1B | 8.8% |
| 93 | MD | Pediatrix Medical Group, Inc. | $1.7B | 8.6% |
| 94 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | $19.5B | 8.6% |
| 95 | HIMS | HIMS & HERS HEALTH, INC. | $3.3B | 8.5% |
| 96 | EHC | Encompass Health Corporation | $10.8B | 8.5% |
| 97 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | $44.2B | 8.4% |
| 98 | SXT | Sensient Technologies Corp | $4.3B | 8.3% |
| 99 | IQV | IQVIA HOLDINGS INC. | $30.3B | 8.3% |
| 100 | CSBR | CHAMPIONS ONCOLOGY, INC. | $83M | 8.3% |
Net Margin Rankings in Other Sectors
Source: SEC EDGAR, Polygon.io